Grindwell Norton Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 10, 2025, 8:57 pm

Competitors of Grindwell Norton Ltd

All Competitor Stocks of Grindwell Norton Ltd

Quarterly Result

Last Updated: August 1, 2025, 8:40 pm

Below is a detailed analysis of the quarterly data for Grindwell Norton Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 703.00 Cr.. The value appears to be declining and may need further review. It has decreased from 710.00 Cr. (Mar 2025) to 703.00 Cr., marking a decrease of 7.00 Cr..
• For Expenses, as of Jun 2025, the value is 574.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 582.00 Cr. (Mar 2025) to 574.00 Cr., marking a decrease of 8.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 130.00 Cr.. The value appears strong and on an upward trend. It has increased from 127.00 Cr. (Mar 2025) to 130.00 Cr., marking an increase of 3.00 Cr..
• For OPM %, as of Jun 2025, the value is 18.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 18.00%.
• For Other Income, as of Jun 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Mar 2025) to 24.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.00 Cr..
• For Depreciation, as of Jun 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Mar 2025) to 26.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 126.00 Cr.. The value appears strong and on an upward trend. It has increased from 123.00 Cr. (Mar 2025) to 126.00 Cr., marking an increase of 3.00 Cr..
• For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 24.00% (Mar 2025) to 25.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 94.00 Cr.. The value appears strong and on an upward trend. It has increased from 93.00 Cr. (Mar 2025) to 94.00 Cr., marking an increase of 1.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 8.53. The value appears strong and on an upward trend. It has increased from 8.36 (Mar 2025) to 8.53, marking an increase of 0.17.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:16 am

Growth

Last Updated: September 5, 2025, 5:25 am

Balance Sheet

Last Updated: November 9, 2025, 2:06 pm

Below is a detailed analysis of the balance sheet data for Grindwell Norton Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 55.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 55.00 Cr..
• For Reserves, as of Sep 2025, the value is 2,226.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,200.00 Cr. (Mar 2025) to 2,226.00 Cr., marking an increase of 26.00 Cr..
• For Borrowings, as of Sep 2025, the value is 80.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 84.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 4.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 780.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 716.00 Cr. (Mar 2025) to 780.00 Cr., marking an increase of 64.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 3,142.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,055.00 Cr. (Mar 2025) to 3,142.00 Cr., marking an increase of 87.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 883.00 Cr.. The value appears to be declining and may need further review. It has decreased from 886.00 Cr. (Mar 2025) to 883.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Sep 2025, the value is 51.00 Cr.. The value appears strong and on an upward trend. It has increased from 26.00 Cr. (Mar 2025) to 51.00 Cr., marking an increase of 25.00 Cr..
• For Investments, as of Sep 2025, the value is 927.00 Cr.. The value appears strong and on an upward trend. It has increased from 892.00 Cr. (Mar 2025) to 927.00 Cr., marking an increase of 35.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,281.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,251.00 Cr. (Mar 2025) to 1,281.00 Cr., marking an increase of 30.00 Cr..
• For Total Assets, as of Sep 2025, the value is 3,142.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,055.00 Cr. (Mar 2025) to 3,142.00 Cr., marking an increase of 87.00 Cr..

Notably, the Reserves (2,226.00 Cr.) exceed the Borrowings (80.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Grindwell Norton Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 33.30. This value is within the healthy range. It has decreased from 34.65 (Mar 24) to 33.30, marking a decrease of 1.35.
• For Diluted EPS (Rs.), as of Mar 25, the value is 33.30. This value is within the healthy range. It has decreased from 34.65 (Mar 24) to 33.30, marking a decrease of 1.35.
• For Cash EPS (Rs.), as of Mar 25, the value is 41.81. This value is within the healthy range. It has increased from 41.12 (Mar 24) to 41.81, marking an increase of 0.69.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 203.41. It has increased from 186.36 (Mar 24) to 203.41, marking an increase of 17.05.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 203.71. It has increased from 186.67 (Mar 24) to 203.71, marking an increase of 17.04.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 253.94. It has increased from 242.66 (Mar 24) to 253.94, marking an increase of 11.28.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 53.56. This value is within the healthy range. It has increased from 53.08 (Mar 24) to 53.56, marking an increase of 0.48.
• For PBIT / Share (Rs.), as of Mar 25, the value is 45.19. This value is within the healthy range. It has decreased from 46.68 (Mar 24) to 45.19, marking a decrease of 1.49.
• For PBT / Share (Rs.), as of Mar 25, the value is 44.35. This value is within the healthy range. It has decreased from 45.95 (Mar 24) to 44.35, marking a decrease of 1.60.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 33.45. This value is within the healthy range. It has decreased from 34.72 (Mar 24) to 33.45, marking a decrease of 1.27.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 33.30. This value is within the healthy range. It has decreased from 34.65 (Mar 24) to 33.30, marking a decrease of 1.35.
• For PBDIT Margin (%), as of Mar 25, the value is 21.09. This value is within the healthy range. It has decreased from 21.87 (Mar 24) to 21.09, marking a decrease of 0.78.
• For PBIT Margin (%), as of Mar 25, the value is 17.79. This value is within the healthy range. It has decreased from 19.23 (Mar 24) to 17.79, marking a decrease of 1.44.
• For PBT Margin (%), as of Mar 25, the value is 17.46. This value is within the healthy range. It has decreased from 18.93 (Mar 24) to 17.46, marking a decrease of 1.47.
• For Net Profit Margin (%), as of Mar 25, the value is 13.17. This value exceeds the healthy maximum of 10. It has decreased from 14.30 (Mar 24) to 13.17, marking a decrease of 1.13.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.11. This value is within the healthy range. It has decreased from 14.27 (Mar 24) to 13.11, marking a decrease of 1.16.
• For Return on Networth / Equity (%), as of Mar 25, the value is 16.37. This value is within the healthy range. It has decreased from 18.69 (Mar 24) to 16.37, marking a decrease of 2.32.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.66. This value is within the healthy range. It has decreased from 23.50 (Mar 24) to 20.66, marking a decrease of 2.84.
• For Return On Assets (%), as of Mar 25, the value is 12.06. This value is within the healthy range. It has decreased from 13.85 (Mar 24) to 12.06, marking a decrease of 1.79.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.96. It has decreased from 1.04 (Mar 24) to 0.96, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 25, the value is 2.83. This value is within the healthy range. It has increased from 2.76 (Mar 24) to 2.83, marking an increase of 0.07.
• For Quick Ratio (X), as of Mar 25, the value is 2.06. This value exceeds the healthy maximum of 2. It has increased from 1.90 (Mar 24) to 2.06, marking an increase of 0.16.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.85. This value is below the healthy minimum of 4. It has decreased from 1.86 (Mar 24) to 1.85, marking a decrease of 0.01.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 51.04. This value exceeds the healthy maximum of 50. It has increased from 41.84 (Mar 24) to 51.04, marking an increase of 9.20.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 40.79. This value is within the healthy range. It has increased from 35.32 (Mar 24) to 40.79, marking an increase of 5.47.
• For Earning Retention Ratio (%), as of Mar 25, the value is 48.96. This value is within the healthy range. It has decreased from 58.16 (Mar 24) to 48.96, marking a decrease of 9.20.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 59.21. This value is within the healthy range. It has decreased from 64.68 (Mar 24) to 59.21, marking a decrease of 5.47.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 63.44. This value is within the healthy range. It has decreased from 75.75 (Mar 24) to 63.44, marking a decrease of 12.31.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 40.62. This value is within the healthy range. It has decreased from 50.59 (Mar 24) to 40.62, marking a decrease of 9.97.
• For Enterprise Value (Cr.), as of Mar 25, the value is 18,426.89. It has decreased from 20,843.35 (Mar 24) to 18,426.89, marking a decrease of 2,416.46.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.55. This value exceeds the healthy maximum of 3. It has decreased from 7.76 (Mar 24) to 6.55, marking a decrease of 1.21.
• For EV / EBITDA (X), as of Mar 25, the value is 31.07. This value exceeds the healthy maximum of 15. It has decreased from 35.46 (Mar 24) to 31.07, marking a decrease of 4.39.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.64. This value exceeds the healthy maximum of 3. It has decreased from 7.83 (Mar 24) to 6.64, marking a decrease of 1.19.
• For Retention Ratios (%), as of Mar 25, the value is 48.95. This value is within the healthy range. It has decreased from 58.15 (Mar 24) to 48.95, marking a decrease of 9.20.
• For Price / BV (X), as of Mar 25, the value is 8.29. This value exceeds the healthy maximum of 3. It has decreased from 10.25 (Mar 24) to 8.29, marking a decrease of 1.96.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.64. This value exceeds the healthy maximum of 3. It has decreased from 7.83 (Mar 24) to 6.64, marking a decrease of 1.19.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness